The BCR/ABL‐inhibitors imatinib, nilotinib and dasatinib differentially affect NK cell reactivity
Julia Salih(University of Tübingen), Matthias Krusch(Zero to Three)
Cited by 90
Related Papers
No related papers found
Powered by citation graph analysis